[Atherosclerosis and oncogenes].
Atherosclerosis, a leading cause of mortality in the developed world, has mainly been studied with respect to the pathogenic role of lipids. However, over the last few years, a new avenue of research has stemmed from Benditt's monoclonal theory which linkens the atheroma plaque to a benign tumor developed from a single smooth muscle cell. Investigations into mechanisms capable of initiating this monoclonal cell growth have included studies of protooncogene activation. Barrett and Benditt have reported increased expression of the sis oncogene in the atheroma plaque; the product of this oncogene is very similar to the beta chain of platelet-derived growth factor (PDGF) which may play a role in the development of the atheroma plaque. These recent studies focusing on the earliest step of formation of the atheroma plaque, ie, cell growth, complement the pathophysiologic theories studied until now.
Onraed-Dupriez
B
B
Laboratoire de Biochimie, Hôpital Cardiologique, CHR de Lille, France.
D001158:Arteries / Q000503:physiopathology; D001161:Arteriosclerosis / Q000235:genetics* / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D009131:Muscle, Smooth, Vascular / Q000503:physiopathology; D009857:Oncogenes / Q000235:genetics*; D010982:Platelet-Derived Growth Factor / Q000502:physiology*; D011519:Proto-Oncogenes / Q000235:genetics; D012201:Reward
D010982:Platelet-Derived Growth Factor
Athérosclérose et oncogènes.